Diabetology's Oral Insulin-Human Test Results To Be Presented At American Diabetes Association 64th Scientific Sessions In Orlando June 4-7th 
10/19/2005 5:11:23 PM

Diabetology Ltd, the British based company developing an oral form of Insulin for Diabetics, announced today that a scientific abstract based on the first successful human tests carried out with its Capsulin® form of Oral Insulin has been accepted for presentation at the 64th Scientific sessions of the American Diabetes Association congress in Orlando, Florida in June. Dr Jim Phillips, Diabetology’s managing director, said “We are extremely pleased that our progressive work towards developing a new way of giving Insulin is being recognised at one of the worlds leading Diabetes congresses” in addition he stated that Diabetology is currently awaiting a green light to commence testing Capsulin® in Diabetic volunteers.